Cargando…
Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus
The objective of this study was to determine the result reproducibility and performance of the BD Onclarity human papillomavirus (HPV) assay (Onclarity) on the BD Viper LT platform using both contrived and clinical specimens. Reproducibility was assessed in BD SurePath liquid-based cytology (LBC) me...
Autores principales: | Young, Stephen, Vaughan, Laurence, Yanson, Karen, Eckert, Karen, Li, Aojun, Harris, James, Ermel, Aaron, Williams, James A., Al-Ghoul, Mohammad, Cammarata, Catherine L., Taylor, Stephanie N., Luff, Ronald, Cooper, Charles K., Van Der Pol, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771472/ https://www.ncbi.nlm.nih.gov/pubmed/33087435 http://dx.doi.org/10.1128/JCM.02048-20 |
Ejemplares similares
-
The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016) -
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity Trial
por: Wright, Thomas C, et al.
Publicado: (2019) -
HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial
por: Stoler, Mark H, et al.
Publicado: (2019) -
Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test
por: Young, Stephen, et al.
Publicado: (2020) -
Universal Human Papillomavirus Typing Assay: Whole-Genome Sequencing following Target Enrichment
por: Li, Tengguo, et al.
Publicado: (2017)